Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 1.10
A's Cash to Debt is ranked lower than
55% of the 2543 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 4.46 vs. A: 1.10 )
A' s 10-Year Cash to Debt Range
Min: 0.63   Max: No Debt
Current: 1.1

Equity to Asset 0.51
A's Equity to Asset is ranked higher than
53% of the 2512 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 0.57 vs. A: 0.51 )
A' s 10-Year Equity to Asset Range
Min: 0.31   Max: 0.71
Current: 0.51

0.31
0.71
Interest Coverage 8.89
A's Interest Coverage is ranked lower than
57% of the 1455 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 105.08 vs. A: 8.89 )
A' s 10-Year Interest Coverage Range
Min: 0.53   Max: 9999.99
Current: 8.89

0.53
9999.99
F-Score: 6
Z-Score: 4.12
M-Score: -2.72
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 14.02
A's Operating margin (%) is ranked higher than
91% of the 2403 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 3.75 vs. A: 14.02 )
A' s 10-Year Operating margin (%) Range
Min: -26.74   Max: 16.32
Current: 14.02

-26.74
16.32
Net-margin (%) 10.68
A's Net-margin (%) is ranked higher than
88% of the 2405 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 3.08 vs. A: 10.68 )
A' s 10-Year Net-margin (%) Range
Min: -46.06   Max: 66.5
Current: 10.68

-46.06
66.5
ROE (%) 13.70
A's ROE (%) is ranked higher than
87% of the 2375 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 5.84 vs. A: 13.70 )
A' s 10-Year ROE (%) Range
Min: -72.88   Max: 90.65
Current: 13.7

-72.88
90.65
ROA (%) 6.78
A's ROA (%) is ranked higher than
83% of the 2410 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 2.93 vs. A: 6.78 )
A' s 10-Year ROA (%) Range
Min: -32.68   Max: 44.88
Current: 6.78

-32.68
44.88
ROC (Joel Greenblatt) (%) 51.68
A's ROC (Joel Greenblatt) (%) is ranked higher than
93% of the 2402 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 11.83 vs. A: 51.68 )
A' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -66.02   Max: 73.16
Current: 51.68

-66.02
73.16
Revenue Growth (%) 8.40
A's Revenue Growth (%) is ranked higher than
80% of the 1831 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 2.60 vs. A: 8.40 )
A' s 10-Year Revenue Growth (%) Range
Min: -22.8   Max: 18.4
Current: 8.4

-22.8
18.4
EBITDA Growth (%) 11.50
A's EBITDA Growth (%) is ranked higher than
78% of the 1488 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.90 vs. A: 11.50 )
A' s 10-Year EBITDA Growth (%) Range
Min: -27.7   Max: 76.8
Current: 11.5

-27.7
76.8
EPS Growth (%) 2.70
A's EPS Growth (%) is ranked higher than
68% of the 1341 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 2.40 vs. A: 2.70 )
A' s 10-Year EPS Growth (%) Range
Min: 2.7   Max: 135.6
Current: 2.7

2.7
135.6
» A's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2013

A Guru Trades in Q2 2013

Louis Moore Bacon 25,000 sh (New)
Richard Perry 1,500,000 sh (New)
Ron Baron 26,000 sh (+13.04%)
Sarah Ketterer 580,600 sh (+0.36%)
David Dreman 75,770 sh (+0.07%)
Richard Snow 1,375,051 sh (+0.04%)
Brian Rogers 2,250,000 sh (unchged)
Vanguard Health Care Fund 6,416,100 sh (unchged)
Dodge & Cox Sold Out
Caxton Associates Sold Out
Joel Greenblatt Sold Out
PRIMECAP Management 95,909 sh (-0.15%)
Scott Black 146,464 sh (-0.22%)
Chris Davis 3,679,231 sh (-3.49%)
Robert Olstein 161,000 sh (-7.47%)
Paul Tudor Jones 325,000 sh (-40.91%)
Pioneer Investments 143,800 sh (-62.86%)
Jean-Marie Eveillard 316,751 sh (-76.52%)
Steven Cohen 69,266 sh (-89.35%)
» More
Q3 2013

A Guru Trades in Q3 2013

Joel Greenblatt 20,773 sh (New)
George Soros 24,425 sh (New)
John Hussman 157,000 sh (New)
Steven Cohen 234,129 sh (+238.01%)
Sarah Ketterer 848,520 sh (+46.15%)
George Soros 17,500 sh (unchged)
Caxton Associates 600,000 sh (unchged)
Ron Baron 26,000 sh (unchged)
Brian Rogers 2,250,000 sh (unchged)
Louis Moore Bacon Sold Out
Scott Black Sold Out
Richard Perry Sold Out
Jean-Marie Eveillard Sold Out
PRIMECAP Management 94,709 sh (-1.25%)
Chris Davis 3,625,285 sh (-1.47%)
Richard Snow 1,316,336 sh (-4.27%)
Vanguard Health Care Fund 5,899,000 sh (-8.06%)
Pioneer Investments 114,902 sh (-20.1%)
Robert Olstein 125,000 sh (-22.36%)
Paul Tudor Jones 251,300 sh (-22.68%)
David Dreman 1,991 sh (-97.37%)
» More
Q4 2013

A Guru Trades in Q4 2013

Caxton Associates 43,510 sh (New)
Jim Simons 276,700 sh (New)
John Hussman 313,000 sh (+99.36%)
George Soros 17,500 sh (unchged)
Ron Baron 26,000 sh (unchged)
Caxton Associates 60,000 sh (unchged)
George Soros 24,425 sh (unchged)
Joel Greenblatt Sold Out
Paul Tudor Jones Sold Out
Sarah Ketterer Sold Out
PRIMECAP Management 94,609 sh (-0.11%)
Chris Davis 3,585,021 sh (-1.11%)
Vanguard Health Care Fund 5,624,200 sh (-4.66%)
Pioneer Investments 108,367 sh (-5.69%)
Richard Snow 1,204,695 sh (-8.48%)
Robert Olstein 85,000 sh (-32%)
Brian Rogers 1,497,454 sh (-33.45%)
David Dreman 550 sh (-72.38%)
Steven Cohen 45,324 sh (-80.64%)
» More
Q1 2014

A Guru Trades in Q1 2014

Paul Tudor Jones 6,156 sh (New)
Signature Select Canadian Fund 191,600 sh (New)
David Dreman 2,134 sh (+288%)
Steven Cohen 128,546 sh (+183.62%)
Vanguard Health Care Fund 5,624,200 sh (unchged)
John Hussman 313,000 sh (unchged)
Ron Baron 26,000 sh (unchged)
Caxton Associates 60,000 sh (unchged)
Jim Simons Sold Out
Pioneer Investments Sold Out
George Soros Sold Out
Robert Olstein Sold Out
Caxton Associates Sold Out
Brian Rogers Sold Out
PRIMECAP Management 94,009 sh (-0.63%)
Chris Davis 3,246,884 sh (-9.43%)
Richard Snow 649,036 sh (-46.12%)
» More
» Details

Insider Trades

Latest Guru Trades with A

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
George Soros 2014-03-31 Sold Out 0.01%$54.69 - $60.93 $ 56.03-3%0
David Dreman 2014-03-31 Add 288%0.01%$54.69 - $60.93 $ 56.03-3%2134
John Hussman 2013-12-31 Add 99.36%0.65%$49.95 - $57.89 $ 56.036%313000
Joel Greenblatt 2013-12-31 Sold Out 0.04%$49.95 - $57.89 $ 56.036%0
David Dreman 2013-12-31 Reduce -72.38%0.01%$49.95 - $57.89 $ 56.036%550
Richard Perry 2013-09-30 Sold Out 1.6%$43.09 - $52.15 $ 56.0319%0
Scott Black 2013-09-30 Sold Out 0.75%$43.09 - $52.15 $ 56.0319%0
John Hussman 2013-09-30 New Buy0.44%$43.09 - $52.15 $ 56.0319%157000
David Dreman 2013-09-30 Reduce -97.37%0.11%$43.09 - $52.15 $ 56.0319%1991
Joel Greenblatt 2013-09-30 New Buy0.04%$43.09 - $52.15 $ 56.0319%20773
Jean-Marie Eveillard 2013-09-30 Sold Out 0.04%$43.09 - $52.15 $ 56.0319%0
George Soros 2013-09-30 New Buy0.01%$43.09 - $52.15 $ 56.0319%24425
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Agilent Technologies Inc

Brian Rogers Changes His Mind on Apple at Lower Valuation
Back in March 2012, when many firms were cashing in on Apple (AAPL)’s astronomical growth, Bloomberg noted that the stock was “conspicuously absent” from Brian Rogers’ portfolio. Rogers, the chairman and chief investment officer overseeing $500 billion at T. Rowe Price, responded at the time that Apple was not right for his firm’s value funds. A little while later, he did an about-face on the stock, taking a large position and adding shares as recently as the third quarter. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 27.20
A's P/E(ttm) is ranked higher than
66% of the 2657 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 31.80 vs. A: 27.20 )
A' s 10-Year P/E(ttm) Range
Min: 3.84   Max: 67.48
Current: 27.2

3.84
67.48
P/B 3.30
A's P/B is ranked lower than
58% of the 2657 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.64 vs. A: 3.30 )
A' s 10-Year P/B Range
Min: 1.7   Max: 5.48
Current: 3.3

1.7
5.48
P/S 2.80
A's P/S is ranked lower than
60% of the 2657 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 0.99 vs. A: 2.80 )
A' s 10-Year P/S Range
Min: 0.83   Max: 5.45
Current: 2.8

0.83
5.45
PFCF 20.60
A's PFCF is ranked higher than
76% of the 2657 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 82.23 vs. A: 20.60 )
A' s 10-Year PFCF Range
Min: 7.53   Max: 101.51
Current: 20.6

7.53
101.51
EV-to-EBIT 19.48
A's EV-to-EBIT is ranked higher than
69% of the 2657 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 23.84 vs. A: 19.48 )
A' s 10-Year EV-to-EBIT Range
Min: 7.7   Max: 451.6
Current: 19.48

7.7
451.6
PEG 0.60
A's PEG is ranked higher than
94% of the 2657 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 9999.00 vs. A: 0.60 )
A' s 10-Year PEG Range
Min: 0.6   Max: 10.4
Current: 0.6

0.6
10.4
Shiller P/E 26.80
A's Shiller P/E is ranked higher than
90% of the 2657 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 9999.00 vs. A: 26.80 )
A' s 10-Year Shiller P/E Range
Min: 8.97   Max: 125.74
Current: 26.8

8.97
125.74
Current Ratio 3.13
A's Current Ratio is ranked higher than
81% of the 2530 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.96 vs. A: 3.13 )
A' s 10-Year Current Ratio Range
Min: 1.61   Max: 3.53
Current: 3.13

1.61
3.53
Quick Ratio 2.49
A's Quick Ratio is ranked higher than
81% of the 2530 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.44 vs. A: 2.49 )
A' s 10-Year Quick Ratio Range
Min: 1.04   Max: 3.04
Current: 2.49

1.04
3.04

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.92
A's Dividend Yield is ranked lower than
73% of the 1669 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.64 vs. A: 0.92 )
A' s 10-Year Dividend Yield Range
Min: 0.22   Max: 1.02
Current: 0.92

0.22
1.02
Dividend Payout 0.24
A's Dividend Payout is ranked higher than
86% of the 2657 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 9999.00 vs. A: 0.24 )
A' s 10-Year Dividend Payout Range
Min: 0.09   Max: 0.32
Current: 0.24

0.09
0.32
Yield on cost (5-Year) 0.90
A's Yield on cost (5-Year) is ranked lower than
75% of the 1708 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.80 vs. A: 0.90 )
A' s 10-Year Yield on cost (5-Year) Range
Min: 0.22   Max: 1.02
Current: 0.9

0.22
1.02
Share Buyback Rate 0.80
A's Share Buyback Rate is ranked higher than
86% of the 1323 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: -1.00 vs. A: 0.80 )
A' s 10-Year Share Buyback Rate Range
Min: 9.5   Max: -7
Current: 0.8

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 10.80
A's Price/Tangible Book is ranked lower than
67% of the 2657 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.99 vs. A: 10.80 )
A' s 10-Year Price/Tangible Book Range
Min: 1.54   Max: 17.47
Current: 10.8

1.54
17.47
Price/DCF (Projected) 1.20
A's Price/DCF (Projected) is ranked higher than
90% of the 2656 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 9999.00 vs. A: 1.20 )
A' s 10-Year Price/DCF (Projected) Range
Min: 0.87   Max: 4.15
Current: 1.2

0.87
4.15
Price/Median PS Value 1.10
A's Price/Median PS Value is ranked higher than
61% of the 2657 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.17 vs. A: 1.10 )
A' s 10-Year Price/Median PS Value Range
Min: 0.41   Max: 1.73
Current: 1.1

0.41
1.73
Price/Peter Lynch Fair Value 1.10
A's Price/Peter Lynch Fair Value is ranked higher than
95% of the 2657 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 9999.00 vs. A: 1.10 )
A' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.42   Max: 6.85
Current: 1.1

0.42
6.85
Price/Graham Number 3.50
A's Price/Graham Number is ranked higher than
55% of the 2657 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 2.33 vs. A: 3.50 )
A' s 10-Year Price/Graham Number Range
Min: 1.09   Max: 4.97
Current: 3.5

1.09
4.97
Earnings Yield (Greenblatt) 5.10
A's Earnings Yield (Greenblatt) is ranked higher than
57% of the 2171 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 6.50 vs. A: 5.10 )
A' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.2   Max: 13
Current: 5.1

0.2
13
Forward Rate of Return (Yacktman) 36.56
A's Forward Rate of Return (Yacktman) is ranked higher than
96% of the 1579 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 3.06 vs. A: 36.56 )
A' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -1.2   Max: 37.4
Current: 36.56

-1.2
37.4

Business Description

Industry: Computer Hardware » Scientific & Technical Instruments
Compare:ROP, GRMN, HXGBY, TRMB, NANO » details
Traded in other countries:AG8.Germany
Agilent Technologies, Inc. was incorporated in Delaware in May 1999. The Company is a measurement company, providing core bio-analytical and electronic measurement solutions to the life sciences, chemical analysis, communications and electronics industries. The four operating segments are Life sciences business, Chemical Analysis Business, Diagnostics and Genomics Business and Electronic Measurement Business. Life sciences business provides application-focused solutions that include instruments, software, consumables, and services that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Key product categories in life sciences include: liquid chromatography systems, columns and components; liquid chromatography mass spectrometry systems; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; nucleic acid solutions; Nuclear Magnetic Resonance ; Magnetic Resonance Imaging and X-Ray Diffraction systems and services and support for the aforementioned products. The Chemical Analysis business provides application-focused solutions that include instruments, software, consumables, and services that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Key product categories in chemical analysis include: gas chromatography systems, columns and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; software and data systems; vacuum pumps and measurement technologies; services and support for its products. Diagnostics and genomics business provides solutions that include reagents, instruments, software and consumables that enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its offerings include immunohistochemistry, In Situ Hybridization, Hematoxylin and Eosin Staining, special staining, DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, as well as automated gel electrophoresis-based sample analysis systems. Electronic Measurement Business provides electronic measurement instruments and systems, software design tools and related services that are used in the design, development, manufacture, installation, deployment and operation of electronics equipment, and microscopy products. Related services include start-up assistance, instrument productivity and application services and instrument calibration and repair. The Company's primary competitors are Bruker Corp., Danaher Corporation, Thermo Fisher Scientific Inc., Waters Corp, PerkinElmer Inc., Shimadzu Corporation, Ventana Me
» More Articles for A

Headlines

Articles On GuruFocus.com
Agilent Has Focused on Several Strategic Actions Mar 20 2014 
Chris Davis' Davis Funds 2013 Portfolio Managers Update Feb 27 2014 
$500 Billion Manager Brian Rogers’ About-Face on Apple Inc. Dec 02 2013 
The Best Yielding Ex-Dividend Stocks on March 28, 2013 Mar 27 2013 
comment on A Mar 15 2013 
comment on A Mar 15 2013 
Edward Owens’ 3 Biggest Stock Increases Feb 05 2013 
My 4 Favorites of the 32 Stocks with Dividend Growth from Last Week Jan 20 2013 
comment on A Sep 20 2012 
Value Investor Robert Olstein: Market Is Overreacting and His Top Picks Aug 10 2012 

More From Our Partners
Why GameStop (GME) Stock Is Slumping Today Jul 29 2014 - THESTREET
Why Xbox Could Launch Its Own Streaming Service Jul 29 2014 - THESTREET

More From Other Websites
Agilent Technologies Announces No-Cost, Six-Month Availability of Modelithics COMPLETE Library for... Jul 28 2014
Agilent Technologies Signs Co-Marketing Agreement with MRM Proteomics to Advance Quantitative... Jul 24 2014
Agilent Technologies Signs Co-Marketing Agreement with MRM Proteomics to Advance Quantitative... Jul 24 2014
Agilent Technologies' PXIe Modular Vector Signal Test Solution Accelerates Smarter Micro's Power... Jul 22 2014
TRADE NEWS: Agilent Technologies’ PXIe Modular Vector Signal Test Solution Accelerates Smarter... Jul 22 2014
Agilent: The Future Is Blurred Jul 21 2014
Roof Leaker To Watch: Agilent Technologies (A) Jul 17 2014
Danaher Q2 Earnings, Guidance Disappoint Wall Street Jul 17 2014
Agilent Technologies Introduces New Exome Optimized for Clinical Research Sequencing Jul 16 2014
TRADE NEWS: Agilent Technologies Introduces New Exome Optimized for Clinical Research Sequencing Jul 16 2014
Agilent: Still Attractive Enough Jul 15 2014
Agilent Technologies Hosts 5G Test Summit at FuTURE MOBILE COMMUNICATION FORUM Jul 15 2014
Agilent Technologies Introduces Custom Oligo FISH Solution for Cytogenetic and Pathology Research... Jul 15 2014
3 Health Services Stocks Dragging The Industry Down Jul 15 2014
TRADE NEWS: Agilent Technologies Introduces Custom Oligo FISH Solution for Cytogenetic and Pathology... Jul 15 2014
Agilent Technologies Cary 7000 Universal Measurement Spectrophotometer Wins R&D 100 Award Jul 14 2014
TRADE NEWS: Agilent Technologies Cary 7000 Universal Measurement Spectrophotometer Wins R&D 100... Jul 14 2014
Agilent Technologies Introduces Industry's Most Accurate Test Solution for USB 3.1 Receivers Jul 09 2014
TRADE NEWS: Agilent Technologies Introduces Industry’s Most Accurate Test Solution for USB 3.1... Jul 09 2014
Agilent Technologies Introduces Industry's First 100G Ethernet Compliance Test Applications Jul 08 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide